Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

Items 41-50 of 62

Page
per page
  1. NU 9056
    A4492 NU 9056
    Target: Histone Acetyltransferases (HATs)
    Summary: KAT5 (Tip60) HAT inhibitor
      <10 mg/mL
  2. Romidepsin (FK228, depsipeptide)
    A8173 Romidepsin (FK228, depsipeptide)
     7 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1/HDAC2 inhibitor, potent and selective
      ≥27.04 mg/mL
  3. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  4. ZM 447439
    A4113 ZM 447439
    Target: Aurora Kinases|MEK|Src|Lck
    Summary: Aurora Kinase inhibitor,potent and selective
      ≥25.7 mg/mL
  5. Bromodomain Inhibitor, (+)-JQ1
    A1910 Bromodomain Inhibitor, (+)-JQ1
     38 Citation
    Target: Bromodomains
    Summary: BET bromodomain inhibitor
      ≥22.85 mg/mL
  6. Rocilinostat (ACY-1215)
    A4083 Rocilinostat (ACY-1215)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Selective HDAC6 inhibitor
      ≥21.675 mg/mL
  7. ME0328
    A8808 ME0328
    Target: PARP
    Summary: PARP inhibitor,potent and selective
      ≥71.43 mg/mL
  8. NSC 87877
    A4544 NSC 87877
    Target: PTP
    Summary: Shp2 /shp1 PTP inhibitor
      ≥45.9 mg/mL
  9. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  10. PFI-1 (PF-6405761)
    A4184 PFI-1 (PF-6405761)
     1 Citation
    Target: Bromodomains
    Summary: BET inhibitor
      insoluble in H2O; insoluble in EtOH; ≥128.4 mg/mL

Items 41-50 of 62

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 59item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
Specificity
  1. Selective 36item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 12item
  3. Aurora Kinases 13item
  4. EZH2 1 item
  5. Bromodomains 2item
  6. FLT3 5item
  7. PLK 1 item
  8. VEGFR 2item
  9. RET 1 item
  10. Bromodomain-containing proteins(BRDs) 1 item
  11. Hydrolase 1 item
  12. MEK 1 item
  13. FGFR 1 item
  14. Pim 1 item
  15. Sir2-like Family Deacetylases (Sirtuins) 2item
  16. PP1 1 item
  17. PP2A 1 item
  18. Src 3item
  19. Trk Receptors 1 item
  20. STAT 1 item
  21. EGFR 1 item
  22. JAK 9item
  23. Topoisomerases 1 item
  24. DNA Methyltransferases 1 item
  25. LRRK2 1 item
  26. PARP 7item
  27. ALK 1 item
  28. Histamine H1 Receptors 1 item
  29. Hck 1 item
  30. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  31. Cytidine deaminases 1 item
  32. PP4 1 item
  33. c-RET 1 item
  34. VEGFR3/FLT4 1 item
  35. NTRK1/TRKA 1 item
  36. CSF-1R/c-Fms 1 item
  37. PTP 1 item
  38. p53 1 item
  39. Histone Acetyltransferases (HATs) 1 item
  40. Trx 1 item
  41. TYK2 1 item
  42. MUSK 1 item
  43. MAP3K 1 item
  44. Lck 1 item
  45. p21 1 item
  46. FGR 1 item
  47. YES 1 item
  48. Fyn 1 item
  49. ARG 1 item
  50. TRPC channel 1 item
  51. Sirtuin 1 item
Related Disease
  1. Acute Myeloid Leukemia 5item
  2. Bladder Cancer 2item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 6item
  5. Cancer 33item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 2item
  9. Colorectal Cancer 2item
  10. Friedreich's Ataxia 1 item
  11. Glioblastoma 1 item
  12. Glioma 1 item
  13. HIV Infections 1 item
  14. Inflammatory Diseases 1 item
  15. Leukemia 1 item
  16. Lung Cancer 2item
  17. Melanoma 1 item
  18. Multiple Myeloma 1 item
  19. Myelofibrosis 1 item
  20. Neuroblastoma 1 item
  21. Neuronal Protection 1 item
  22. Ovarian Cancer 3item
  23. Pancreatic Cancer 2item
  24. Prostate Cancer 6item
  25. Psoriasis 1 item
  26. Renal Cancer 1 item
  27. Renal Cell Carcinoma 1 item
  28. Rheumatoid Arthritis 2item
  29. Thyroid Cancer 1 item
  30. Type 2 Diabetes 2item